Trials / Unknown
UnknownNCT00078221
Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 180 (planned)
- Sponsor
- OccuLogix · Industry
- Sex
- All
- Age
- 50 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
AMD is a progressive disease of the retina which is nourished by a network of tiny blood vessels. There is evidence to suggest that the flow of nutrients to the retina is impaired in patients with AMD. Rheopheresis blood filtration uses blood filters that deplete excesses of large proteins, fats and other substances from the blood, improving blood flow to the macula, potentially improving vision.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Rheopheresis blood filtration |
Timeline
- Start date
- 1999-08-01
- Completion
- 2005-12-01
- First posted
- 2004-03-01
- Last updated
- 2008-05-09
Locations
8 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00078221. Inclusion in this directory is not an endorsement.